Welcome to the InfoSci Platform
Anticoagulation Options

Anticoagulation Options

Michael Mazzeffi, Ashleigh Lowery
Copyright: © 2019 |Pages: 25
ISBN13: 9781522581857|ISBN10: 1522581855|EISBN13: 9781522581864
DOI: 10.4018/978-1-5225-8185-7.ch022
Cite Chapter Cite Chapter

MLA

Mazzeffi, Michael, and Ashleigh Lowery. "Anticoagulation Options." Coronary and Cardiothoracic Critical Care: Breakthroughs in Research and Practice, edited by Information Resources Management Association, IGI Global, 2019, pp. 474-498. https://doi.org/10.4018/978-1-5225-8185-7.ch022

APA

Mazzeffi, M. & Lowery, A. (2019). Anticoagulation Options. In I. Management Association (Ed.), Coronary and Cardiothoracic Critical Care: Breakthroughs in Research and Practice (pp. 474-498). IGI Global. https://doi.org/10.4018/978-1-5225-8185-7.ch022

Chicago

Mazzeffi, Michael, and Ashleigh Lowery. "Anticoagulation Options." In Coronary and Cardiothoracic Critical Care: Breakthroughs in Research and Practice, edited by Information Resources Management Association, 474-498. Hershey, PA: IGI Global, 2019. https://doi.org/10.4018/978-1-5225-8185-7.ch022

Export Reference

Mendeley
Favorite

Abstract

There are multiple indications for anticoagulation in the cardiac surgery intensive care unit including cardiac valve replacement, mechanical circulatory pumps (ECMO and ventricular assist devices), deep vein thrombosis prophylaxis, treatment of heparin-induced thrombocytopenia, and treatment of other thrombotic conditions including pulmonary embolism. Anticoagulant medications broadly fall into two categories: antiplatelet drugs and inhibitors of protein clotting factors. In this chapter we will review anticoagulant medications, therapeutic drug monitoring, common indications for anticoagulation, and the risks associated with anticoagulation after cardiac surgery.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.